Close

taxonomy for: BD Exec Training

Pharma-Biotech Product & Company Valuation Course

The Pharma-Biotech Product & Company Valuation course is designed to teach a systematic approach to producing a valuation which can be used in investment rounds, mergers/acquisitions, licensing deals or strategic development decisions in the pharma-biotech world. It goes beyond the number-crunching techniques of most consultants and includes difficult to define qualitative factors which shape the risk profile of the company in question.

Valuation is an inherently subjective task which is made even more difficult in the life science industry due its unique challenges: high attrition rates in R&D, long investment cycle, complex technologies and IP situations, etc. Therefore, traditional valuation methods are not suitable. Of particular value in this course is the Product Valuation and Deal Structuring module where you will learn the commonly used rNPV (risk-adjusted Net Present Value) method for calculating the value of a drug in development. Subsequently, you will practice how to structure a licensing deal between companies. You will use an Excel-based tool designed specifically for this module (which can be taken home).

The course will be led by Patrik Feri, who is a leading expert in the valuation of life science companies and his combination of knowledge and experience allows him to speak with authority on the subject. Patrik wrote the first book on the valuation of high-growth companies and holds a Ph.D in the field. His company, Venture Valuation, has completed over 400 independent company and product valuations.

Topics Covered*:

  • Introduction to Valuation
  • Assessing a Company Prior to Valuation
  • Company Valuation and Methods
  • Product Valuation and Methods
  • Deal Structuring

Who should attend?

This is an introductory course and therefore very valuable for pharma and biotech executives who are not familiar with compound and company valuations but need a thorough understanding of the valuation concepts and techniques that are commonly applied in the pharma and biotech industries.

*Content is subject to modification.

Conferences and Events: 
H1: 
Pharma-Biotech Product & Company Valuation Course

Registration Policies

  • Cancellations: Requests must be submitted in writing on or before May 10, 2018, (5:00 pm United States Eastern Daylight Time) to receive a partial refund. A $400 administrative fee will be deducted from all canceled refunds. Requests received after May 10, 2018, will NOT be honored and no course credit will be offered for future years. Substitutions are always accepted (see below) Email cancellation requests to convention@bio.org.
  • Substitutions: You may transfer your registration to another individual or make changes by sending your request to convention@bio.org no later than June 1, 2018 (5:00 pm United States Eastern Daylight Time)
  • A government-issued photo ID (driver’s license or passport) is required at check-in. Badges will not be issued without proper identification
  • Your company must be a BIO member in good standing on or before June 8, 2018 to receive the BIO member rate
  • There are no special organizational rates for the courses. The only rates offered are Member and nonmember rates.

 

Conferences and Events: 
H1: 
Executive Training Registration Policies

Supporting Organizations

AUTM     

Industry Supporters

     

Conferences and Events: 
H1: 
2018 Supporting Organizations

Advanced Business Development Course

The Advanced Business Development Course is designed for executives and business development professionals interested in bringing their skills in valuation, deal structuring, due diligence, negotiation and contracts to the next level. During this intense, three-day workshop attendees will receive hands-on, advanced training from veteran business development professionals and legal advisers using real world case studies. In addition, attendees will be split into teams to conduct a mock negotiation over rights for a clinical stage compound.

The faculty is drawn from among the most experienced business development professionals in the biotech drug development industry as well as big pharma, many of whom have been instructors in other programs, and all of whom have hands-on experience in the biotech industry.

Topics Covered*:

  • Valuation and Deal Structuring Concepts and Trends
  • Advanced Valuation and Decision Analysis
  • Select Topics of Advanced Deal Structures
  • Market Models, Competition, Cash Flow Estimates
  • Case Study Work
  • Value Distribution and Terms
  • Key Concepts and Building Blocks of a Block Buster Deal
  • Trap Doors, Dead Ends, and Other Do's and Don'ts
  • Current Trends in Licensing Deals

Who should attend?

It is designed for business development professionals who have most likely served as part of a business development or licensing team, but are now preparing to move to a senior manager level role within their organization. Highly experienced business development professionals benefit by getting an update on the latest techniques, revised rules/regulations and honing deal-making skills.

  • Business development & licensing professionals
  • Alliance management professionals
  • R&D personnel who have significant interaction with business development
  • Intellectual property personnel involved in the licensing process
  • Biotech company CEOs
  • Professionals who are new to business development and licensing or who have limited deal experience

*Content is subject to modification.

Conferences and Events: 
H1: 
Advanced Business Development Course

Business Development Fundamentals Course

The Business Development Fundamentals Course is offered as a continuing education program for biopharmaceutical, academic and not for profit professionals as part of BIO’s executive training course series.   The 3 day course is instructed by experts in the areas of finance, transactional and intellectual property law, licensing and alliance management, management consulting and strategic commercial development.  The majority have held positions of increasing responsibility in the life sciences industry ranging from biotherapeutics to diagnostics and medical devices.

Course Objectives:

The goal of the course is to provide an intensive and comprehensive educational foundation on the core skills that are needed to be a successful licensing executive in the life sciences industry and a networking platform for attendees.

Topics Covered*:

  • The Role of Intellectual Property In Creating Value
  • Strategic Alliances - Partner and technology opportunity assessment and process, types of deal structures, term sheet development, the role of alliance management
  • Financial Modeling and Valuation in Licensing
  • Contracts Used in Licensing  (CDAs, MTAs, Sponsored Research Agreements, Definitive Agreements )
  • Negotiation and Communication Strategies
  • University Technology Transfer and it’s Role in IP Creation 
  • Case Study

Who should attend?

  • Professionals who are new to business development and licensing or who have limited deal experience.
  • Alliance management, R&D, legal, marketing or academic professionals who desire to learn more about licensing within their organizations or as a career opportunity.
  • Entrepreneurs who have not been exposed to licensing or M&A type transactions but recognize it as a critical strategic initiative for their business.
  • Professionals interested in a comprehensive refresher course in licensing.

If you have any questions about the program, please contact Patricia Sinatra at psinatra221@gmail.com.

*Content is subject to modification.

 

Conferences and Events: 
H1: 
Business Development Fundamentals Course

Industry Supporters

 

 

Conferences and Events: 
H1: 
Industry Supporters

Venue

The courses will be held in advance of the BIO International Convention, taking place in Boston, MA. 

Boston Convention & Exhibition Center

415 Summer St
Boston, MA 02210

 

Conferences and Events: 
H1: 
Executive Training Programs Venue

Register for BIO Business Development Fundamentals Course

Button_1.jpg

2016 Fees

BIO Members $1,920
Non Members $2,400

Please note that registration for the Business Development Fundamentals course is separate from the BIO International Convention registration. To register for the convention please click here.

Registration Policy

  • Cancellation: Requests must be submitted in writing on or before May 3, 2016, (5:00 pm Eastern Time) to receive a partial refund.  A $195 administrative fee will be deducted from all canceled refunds. Requests received after May 3, 2016, will NOT be honored. Email cancellation requests to BD_Registration@bio.org.
  • Substitutions: You may transfer your registration to another individual or make changes by sending your request to BD_Registration@bio.org no later than June 1, 2016.
  • A government-issued photo ID (driver’s license or passport) is required at check-in. Badges will not be issued without proper identification.
  •  Your company must be a BIO member in good standing on or before June 9, 2016 to receive the BIO member rate.

Don’t miss the premier bioscience recruiting event of the year!

Click here for more information on the Career Fair.

Conferences and Events: